当前位置:首页 - 行情中心 - 同和药业(300636) - 财务分析 - 资产负债表

同和药业

(300636)

  

流通市值:26.64亿  总市值:30.93亿
流通股本:3.64亿   总股本:4.23亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金412,014,668.475,019,95584,960,709.82141,963,915.05
应收票据及应收账款115,810,339.9595,519,021.78117,611,560.1987,829,525.65
应收账款115,810,339.9595,519,021.78117,611,560.1987,829,525.65
应收款项融资2,887,08889,3701,920,0006,863,600
预付款项7,438,8343,577,825.327,039,237.0311,526,320.46
其他应收款合计1,864,620.481,371,411.342,282,591.171,268,859.86
存货484,727,180.7474,534,543.08467,125,058.5497,358,472.51
其他流动资产23,916,240.9814,712,349.5910,395,989.5511,135,450.9
流动资产平衡项目0000
流动资产合计1,078,658,972.51664,824,476.11691,335,146.26757,946,144.43
非流动资产:
固定资产591,596,845.22608,509,686.42629,895,643.03645,089,273.79
在建工程896,301,070.72863,964,920.44820,517,482.21772,970,069.79
使用权资产3,041,777.163,253,994.163,466,211.163,678,428.16
无形资产20,394,335.6320,621,940.5320,849,545.4321,077,150.33
递延所得税资产146,469.26148,211.82164,038.64130,232.46
其他非流动资产553,488,626.39251,668,309.1166,886,173.0657,964,179.17
非流动资产平衡项目0000
非流动资产合计2,064,969,124.381,748,167,062.471,641,779,093.531,500,909,333.7
资产平衡项目0000
资产总计3,143,628,096.892,412,991,538.582,333,114,239.792,258,855,478.13
流动负债:
短期借款373,143,064.11405,683,787.98308,841,416.3267,831,908.42
应付票据及应付账款127,849,262.95146,171,945.27163,366,483.1212,823,513.15
其中:应付票据81,501,123.3186,648,051.6196,590,842.498,387,503.4
应付账款46,348,139.6459,523,893.6666,775,640.7114,436,009.75
合同负债1,672,016.552,042,352.332,802,536.4611,686,632.36
应付职工薪酬17,599,125.8316,937,251.9213,624,872.2316,462,936.51
应交税费2,252,080.361,273,382.483,178,489.351,092,886.69
其他应付款合计45,457,809.7545,264,630.847,338,383.8848,078,423.66
一年内到期的非流动负债71,059,462.7271,059,462.7217,059,462.7217,059,462.72
流动负债平衡项目0000
流动负债合计639,032,822.27688,432,813.5556,211,644.04575,035,763.51
非流动负债:
长期借款266,833,318.7305,833,318.7376,333,318.7326,333,318.7
租赁负债2,255,577.252,473,286.622,690,995.992,908,705.36
递延收益3,908,437.43,948,413.663,988,389.924,028,366.18
递延所得税负债40,617,244.4234,942,085.0332,776,923.1630,880,726.28
非流动负债平衡项目0000
非流动负债合计313,614,577.77347,197,104.01415,789,627.77364,151,116.52
负债平衡项目0000
负债合计952,647,400.041,035,629,917.51972,001,271.81939,186,880.03
所有者权益(或股东权益):
实收资本(或股本)423,136,145350,264,883350,264,883350,190,483
资本公积1,279,008,789.92560,313,361.29552,237,148.43543,384,077.29
减:库存股41,574,15142,004,20142,004,20141,424,625
盈余公积51,127,608.7951,127,608.7951,127,608.7951,127,608.79
未分配利润479,282,304.14457,659,968.99449,487,528.76416,391,054.02
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计2,190,980,696.851,377,361,621.071,361,112,967.981,319,668,598.1
股东权益平衡项目0000
股东权益合计2,190,980,696.851,377,361,621.071,361,112,967.981,319,668,598.1
负债和股东权益合计3,143,628,096.892,412,991,538.582,333,114,239.792,258,855,478.13
公告日期2023-10-262023-08-292023-04-242023-04-24
审计意见(境内)标准无保留意见
TOP↑